'Loop' domain deletional mutant of bcl-x(L) is as effective as p29bcl- x(L) in inhibiting radiation-induced cytosolic accumulation of cytochrome C (cyt c), caspase-3 activity, and apoptosis

International Journal of Radiation Oncology Biology Physics

Volumn 43, Issue 2, 1999, Pages 423-430

  Burri, Stuart H ^b   Kim, Caryn N ^a   Fang, Guofu ^a   Chang, Brian S ^c   Perkins, Charles ^a   Harris, Wayne ^a   Davis, Lawrence W ^b   Thompson, Craig B ^c   Bhalla, Kapil N ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYTOCHROME C; DNA FRAGMENT; FAS ANTIGEN; LIPOCORTIN 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN S 100;

APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; CELL CYCLE; CELL STRAIN HL 60; CONTROLLED STUDY; CYTOSOL; DELETION MUTANT; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IONIZING RADIATION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; WESTERN BLOTTING;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CASPASE 3; CASPASES; CYTOCHROME C GROUP; CYTOSOL; G2 PHASE; HELIX-LOOP-HELIX MOTIFS; HL-60 CELLS; HUMANS; MITOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0033556689     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00385-X     Document Type: Article

References (56)

1. Meyn R.E. Apoptosis and response to radiation implications for radiation therapy . Oncology. 14:1997;2759-2766.
2. Iliakis G. Cell cycle regulation in irradiated and nonirradiated cells. Semin Oncol. 24:1997;602-615.
3. Haimovitz-Friedman A., Kan C.-C., Ehleiter D., Persuad R.S., McLoughlin M., Fuks Z., Kolesnick R.N. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med. 180:1994;525-535.
4. Reap E.A., Roof K., Maynor K., Borrero M., Booker J., Cohen P.L. Radiation and stress-induced apoptosis A role for Fas/Fas ligand interaction . Proc Natl Acad Sci USA. 94:1997;5750-5755.
5. Levine A.J. p 53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
6. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
7. Chmura S.J., Nodzenski E., Beckett M.A., Kufe D.W., Quintans J., Weichselbaum R.R. Loss of ceramide production confers resistance to radiation-induced apoptosis. Cancer Res. 57:1997;1270-1275.
8. Salveson G.S., Dixit V.M. Caspases intracellular signaling by proteolysis . Cell. 91:1997;443-446.
9. Martin S.J., Green D.R. Protease activation during apoptosis Death by a thousand cuts? Cell. 82:1995;349-352.
10. Liu X., Kim C.N., Yang J., Jemmerson R., Wang X. Induction of apoptotic program in cell-free extracts; requirement for dATP and cytochrome c. Cell. 86:1996;147-157.
11. L as an inhibitor of cytosolic cytochrome c accumulation in DNA damage-induced apoptosis. Proc Natl Acad Sci USA. 94:1997;6939-6942.
12. Zamzami N., Susin S.A., Marchetti P., Hirsch T., Gómez-Monterrey I., Castedo M., Kroemer G. Mitochondrial control of nuclear apoptosis. J Exp Med. 183:1996;1533-1544.
13. Zou H., Henzel W.J., Liu X., Lutschg A., Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell. 90:1997;405-413.
14. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
15. Liu X., Zou H., Slaughter C., Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell. 89:1997;1-20.
16. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 391:1998;43-50.
17. Sakahira H., Enari M., Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature. 391:1998;96-99.
18. L by cytotoxic drug exposure confers resistance to ionizing radiation-induced internucleosomal DNA fragmentation. Cell Growth & Differ. 6:1995;363-370.
19. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med. 3:1997;614-620.
20. L inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells. Cancer Res. 56:1996;4743-4748.
21. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.-I., Jones D.P., Wang X. Prevention of apoptosis by Bcl-2 Release of cytochrome c from mitochondria blocked . Science. 275:1997;1129-1132.
22. L, and Apaf-1 form a ternary complex. J Biol Chem. 573:1998;5841-5845.
23. L interacts with Apaf-1 and inhibits Apaf-1 dependent caspase-9 activation. Proc Natl Acad Sci USA. 95:1998;4386-4391.
24. Reed J.C. Cytochrome c can't live with it - can't live without it . Cell. 91:1997;559-562.
25. L regulates the membrane potential and volume homeostasis of mitochondria. Cell. 91:1997;627-637.
26. L, an inhibitor of programmed cell death. Nature. 381:1996;335-341.
27. L forms an ion channel in synthetic lipid membranes. Nature. 385:1997;353-357.
28. L and Bcl-2. EMBO J. 16:1997;968-977.
29. L overexpression inhibits taxol-induced Yama protease activity and apoptosis. Cell Growth & Differ. 7:1996;1087-1094.
30. Epp E.R., Boyer A.L., Doppke K.P. Underdosing of lesions resulting from lack of electronic equilibrium in upper respiratory air cavities irradiated by 10 MV X-ray beams. Int J Radiat Oncol Biol Phys. 2:1977;613-619.
31. Hopcia K.L., McCarey U.L., Sylvester F.C., Held K.D. Radiation-induced apoptosis in HL60 cells oxygen effect, relationship between apoptosis and loss of clonogenicity, and dependence of time to apoptosis on radiation dose . Radiat Res. 145:1996;315-323.
32. Abend M., Rhein A., Gilbertz K.-P., Blakely W.F., Van Beuningen D. Correlation of micronucleus and apoptosis assays with reproductive cell death. Int J Radiat Biol. 67:1995;315-326.
33. Makepeace C.M., Lyons J.C., Park H.J., Song C.W. Comments on "Radiation-induced apoptosis in HL60 cells oxygen effect, relationship between apoptosis and loss of clonogenicity, and dependence of time to apoptosis on radiation dose" by Hopcia; et al . (Radiat Res 1996;145:315-323) Radiat Res. 146:1996;116-119.
34. Tang C., Willingham M.C., Reed J.C., Miyashita T., Ray S., Ponnathpur V., Huang Y., Mahoney M.E., Bullock G., Bhalla K. High levels of p26Bcl-2 oncoprotein retard Taxol-induced apoptosis in human pre-B leukemia cells. Leukemia. 8:1994;1960-1969.
35. L inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis. Cancer Res. 57:1997;3115-3120.
36. Ray S., Ponnathpur V., Huang Y., Tang C., Mahoney M.E., Ibrado A.M., Bullock G., Bhalla K. 1-β-D-arabinofuranosylcytosine-, mitoxantrone- and paclitaxel-induced apoptosis in HL-60 cells Improved method for detection of internucleosomal DNA fragmentation . Cancer Chemother Pharmacol. 34:1994;365-371.
37. Daryzynkiewicz Z., Bruno S., Del Bino G., Gorczyca W., Hotz M.A., Lassotta P., Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry. 13:1992;795-808.
38. Koopman G., Reutelingsperger C.P.M., Kuijten G.A.M., Keehnen R.M.J., Pals S.T., van Oers M.H.J. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 84:1994;1415-1420.
39. L and Bcl-2 repress a common pathway of cell death. J Exp Med. 182:1995;821-828.
40. Fang G., Chang B.S., Kim C.N., Perkins C., Thompson C.B., Bhalla K. Deletional mutant of `loop' domain of Bcl-2 inhibits Ara-C and etoposide but not taxol-induced cytosolic accumulation of cytochrome c (cyt c) and apoptosis. (Abstr.) Proc Amer Assoc Cancer Res. 39:1998;1214.
41. Haldar S., Jena N., Croce C.M. Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA. 92:1995;4507-4511.
42. Ito T., Deng X., Carr B., May W.S. Bcl-2 phosphorylation required for anti-apoptosis function. J Biol Chem. 272:1997;11671-11673.
43. Cheng S.J., Nodzenski E., Beckett M.A., Kufe D.W., Quintas J., Weichselbaum R.R. Loss of ceramide production confers resistance to radiation-induced apoptosis. Cancer Res. 57:1997;1270-1275.
44. L through caspase interaction. Proc Natl Acad Sci USA. 95:1998;554-559.
45. + transporter. Cancer Res. 58:1998;413-420.
46. Strasser A., Harris A.W., Jacks T., Cory S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell. 79:1994;329-339.
47. Merritt A.J., Allen T.D., Potten C.S., Hickman J.A. Apoptosis in small intestinal epithelial from p53-null mice evidence for a delayed, p53-independent G2/M-associated cell death after γ-irradiation . Oncogene. 14:1997;2759-2766.
48. Huang D.C.S., O'Reilly L.A., Strasser A., Cory S. The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J. 16:1997;4628-4638.
49. Bullock G., Ray S., Reed J.C., Krajewski S., Self S., Ibrado A.M., Huang Y., Nawabi A., Bhalla K. Intracellular metabolism of high dose Ara-C and resulting DNA fragmentation and apoptosis of human AML cells possessing disparate levels of p26Bcl-2 protein. Leukemia. 10:1996;1731-1740.
50. Milner A.E., Grand R.J.A., Vaughan A.T.M., Armitage R.J., Gregory C.D. Differential effects of BCL-2 on survival and proliferation of human B-lymphoma cells following γ-irradiation. Oncogene. 15:1997;1815-1822.
51. Friesen C., Herr I., Krammer P.H., Debatin K.-M. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med. 2:1996;574-577.
52. Watts J.D., Gu M., Polverino A.J., Patterson S.D., Aebersold R. Fas-induced apoptosis of T cells occurs independently of ceramide generation. Proc Natl Acad Sci USA. 94:1997;7292-7296.
53. L can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc Natl Acad Sci USA. 94:1997;3759-3764.
54. Kasibhatla S., Brunner T., Genestier L., Echeverri F., Mahboubi A., Green D.R. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1. Mol Cell. 1:1998;543-551.
55. L depends on normal p53 function. Oncogene. 13:1996;2287-2293.
56. Chen M., Quintans J., Fuks Z., Thompson C., Kufe D.W., Weichselbaum R.R. Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor α, and ceramide. Cancer Res. 55:1995;991-994.